James E. Flynn - Nov 12, 2021 Form 4 Insider Report for Oncology Institute, Inc. (TOIIW)

Signature
/s/ Jonathan Isler, Attorney-in-Fact
Stock symbol
TOIIW
Transactions as of
Nov 12, 2021
Transactions value $
$100,000,000
Form type
4
Date filed
11/16/2021, 08:34 PM
Previous filing
Oct 28, 2021
Next filing
May 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOIIW Class A Common Stock Conversion of derivative security +40 40 Nov 12, 2021 Through DFP Sponsor, LLC F1, F2, F3
transaction TOIIW Class A Common Stock Conversion of derivative security +85.1K 85.1K Nov 12, 2021 Through Deerfield Management Company, L.P. F1, F2, F3, F4
holding TOIIW Class A Common Stock 1.61M Nov 12, 2021 Through Deerfield Partners, L.P. F2, F3
holding TOIIW Class A Common Stock 1.61M Nov 12, 2021 Through Deerfield Private Design Fund IV, L.P. F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TOIIW Series A Common Stock Equivalent Convertible Preferred Stock Purchase $50M +50K +558.97% $1,000.00* 58.9K Nov 12, 2021 Class A Common Stock 5M Through Deerfield Partners, L.P. F2, F3, F5
transaction TOIIW Series A Common Stock Equivalent Convertible Preferred Stock Purchase $50M +50K +558.97% $1,000.00* 58.9K Nov 12, 2021 Class A Common Stock 5M Through Deerfield Private Design Fund IV, L.P. F2, F3, F5
transaction TOIIW Class B Common Stock Other $0 -708K -99.99% $0.00 40 Nov 12, 2021 Class A Common Stock 708K Through DFP Sponsor, LLC F2, F3, F6, F7
transaction TOIIW Class B Common Stock Other $0 -14.9K -14.89% $0.00 85.1K Nov 12, 2021 Class A Common Stock 14.9K Through Deerfield Management Company, L.P. F2, F3, F4, F6, F7
transaction TOIIW Class B Common Stock Conversion of derivative security $0 -40 -100% $0.00* 0 Nov 12, 2021 Class A Common Stock 40 Through DFP Sponsor, LLC F1, F2, F3, F6
transaction TOIIW Class B Common Stock Conversion of derivative security $0 -85.1K -100% $0.00* 0 Nov 12, 2021 Class A Common Stock 85.1K Through Deerfield Management Company, L.P. F1, F2, F3, F4, F6
transaction TOIIW Private Placement Warrants Other +3.18M 3.18M Nov 12, 2021 Class A Common Stock 3.18M $11.50 Through DFP Sponsor, LLC F2, F3, F8
transaction TOIIW Public Warrants Other +625K 625K Nov 12, 2021 Class A Common Stock 625K $11.50 Through Deerfield Partners, L.P. F2, F3, F9
transaction TOIIW Public Warrants Other +625K 625K Nov 12, 2021 Class A Common Stock 625K $11.50 Through Deerfield Private Design Fund IV, L.P. F2, F3, F9
holding TOIIW Series A Common Stock Equivalent Convertible Preferred Stock 45.6K Nov 12, 2021 Class A Common Stock 4.56M Through DFP Sponsor, LLC F2, F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

James E. Flynn is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Upon the closing of the Issuer's initial business combination, each share of Class B Common Stock converted (automatically in accordance with its terms) into one share of Class A Common Stock for no consideration.
F2 This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. ("Deerfield Partners"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. ("Fund IV" and, together with Deerfield Partners, the "Funds"). Deerfield Management Company, L.P. ("Deerfield Management") is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P. Each Fund holds a 37% membership interest in DFP Sponsor, LLC (the "Sponsor").
F3 In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds, the Sponsor and Deerfield Management is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.
F4 Steven Hochberg, a partner in Deerfield Management, served as a director and the chief executive officer of the Issuer until his resignation from such positions on November 12, 2021 (prior to the vote of the Issuer's stockholders in respect of the consummation of the Issuer's initial business combination and prior to the transactions reported herein). The Class A Common Stock owned by Steven Hochberg and reported herein is held for the benefit, and at the direction, of Deerfield Management.
F5 Each share of Series A Common Stock Equivalent Convertible Preferred Stock ("Common Equivalent Preferred Stock") is convertible into 100 shares of Class A Common Stock (subject to adjustment) at any time and from time to time at the election of the holder thereof. The Common Equivalent Preferred Stock has no expiration date. The terms of the Common Equivalent Preferred Stock restrict the conversion of such shares to the extent that, upon such conversion, the number of shares of Class A Common Stock then beneficially owned by the holder and its affiliates and any other person or entities with which such holder would constitute a Section 13(d) "group" would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding.
F6 The shares of Class B Common Stock were convertible into shares of the Issuer's Class A Common Stock as described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-236578) and had no expiration date.
F7 In connection with, and immediately prior to, the closing of the Issuer's initial business combination, pursuant to the Stockholder Support Agreement, dated as of June 28, 2021, DFP Sponsor, LLC (the "Sponsor") forfeited 707,960 shares of Class B Common Stock and Steven Hochberg forfeited 14,887 shares of Class B Common Stock for no consideration.
F8 The Sponsor acquired the Private Placement Warrants from the Issuer in connection with the Issuer's initial public offering on March 13, 2020. As a result of the closing of the Business Combination, the Private Placement Warrants will become exercisable as of the date that is 30 days after the closing of the Issuer's initial business combination (i.e., November 12, 2021). The Private Placement Warrants will expire on November 12, 2026 or earlier upon redemption or liquidation. Prior to the closing of the Issuer's initial business combination, the Sponsor elected to be governed by a Maximum Percentage (as defined in the Private Placement Warrants) of 4.9%.
F9 Each Fund acquired the Public Warrants from the Issuer in connection with the Issuer's initial public offering on March 13, 2020. As a result of the closing of the Issuer's initial business combination, the Public Warrants will become exercisable as of the date that is 30 days after the closing of the Issuer's initial business combination (i.e., November 12, 2021). The Public Warrants will expire on November 12, 2026 or earlier upon redemption or liquidation. Prior to the closing of the Issuer's initial business combination, each fund elected to be governed by a Maximum Percentage (as defined in the Public Warrants) of 4.9%.

Remarks:

Jonathan Isler, Attorney-in-Fact: Power of Attorney, which is hereby incorporated by reference to Exhibit 24 to a Form 4 with regard to DA32 Life Science Tech Acquisition Corp. filed with the Securities and Exchange Commission on August 3, 2021 by Deerfield Partners, L.P., Deerfield Mgmt, L.P., Deerfield Management Company, L.P. and James E. Flynn